###### Significance of this study

What is already known about this subject?
=========================================

-   The two-bag protocol for treating diabetic ketoacidosis (DKA) has been used in pediatric patients with some benefit and cost savings as outlined in the introduction section.

What are the new findings?
==========================

-   This study was conducted in adult subjects with DKA. Our study indicates that the two-bag protocol closes the anion gap earlier than the one-bag protocol in adult patients with DKA. Blood glucose levels improved faster with the two-bag protocol compared with the one-bag protocol with fewer associated episodes of hypoglycemia.

How might these results change the focus of research or clinical practice?
==========================================================================

-   The two-bag protocol could potentially be beneficial in treating patients with DKA compared with the conventional one-bag protocol. Prospective studies need to be designed to evaluate the benefit of the two-bag system in reducing intensive care unit stay and overall cost reduction in DKA management.

Introduction {#s1}
============

Nearly 10% of the population in the USA has diabetes mellitus.[@R1] Diabetic ketoacidosis (DKA) is a well-known, serious, acute metabolic complication. While it is primarily associated with type 1 diabetes mellitus two-thirds of the time, it also occurs in type 2 diabetes mellitus approximately 34% of the time[@R2], often as a manifestation of the syndrome of ketosis-prone diabetes.[@R3] The incidence of DKA continues to rise. The Centers for Disease Control and Prevention (CDC) estimates that there were 140 000 hospital discharges from DKA in 2009 in the USA, about 75% increase over the last two decades[@R4] with an estimated cost annually of \>\$2 billion and accounts for \>500 000 hospital days per year.[@R2]

Along with identification of triggering factors, management of DKA involves correction of hyperglycemia, volume depletion, acid--base derangements and electrolyte imbalances.[@R2] Because of the complexities in the management protocol, many cases of DKA are managed in intensive care units (ICUs) across the USA.[@R5] Losses of fluids and electrolytes are significant causes of mortality and morbidity in DKA. The mortality is \<1% in American adults[@R6]; however, rises to \>5% in the elderly population with significant comorbidities.[@R7] In the USA, the age-adjusted mortality rate for hyperglycemic crisis declined between 1980 and 2009. In 2009, hyperglycemic crises caused 64% lower mortality than in 1980.[@R6]

Evidence-based guidelines for the diagnosis and management of DKA have been published periodically in North America[@R2] and Europe[@R10] improving the understanding and facilitating the development of management protocols. The outcomes of DKA have been shown to improve with adherence to treatment guidelines.[@R11] Minor variants of the commonly used treatment protocol for DKA based on the published guidelines use insulin infusions and intravenous electrolyte solution and dextrose solution when blood sugar drops below 250 mg/dL.[@R2] In order to correct dehydration in patients with DKA, intravenous electrolyte solutions are administered at the beginning of the treatment. As the blood glucose levels fall, a new bag of intravenous fluid with different dextrose concentrations would be ordered, and multiple sequential changes of bags would occur during the course of treatment. Despite their proven effectiveness, a varying degree of non-adherence to guidelines has been documented in the literature compromising the success of published protocols.[@R16] Successful implementation of the conventional DKA protocol requires not only careful assessment of the clinical status of the patient and laboratory values, but frequent changes to intravenous fluids between saline and dextrose solutions.[@R2]

The 'two-bag system' was first described in the early 1990s in pediatric patients. As opposed to the conventional protocol (one-bag system), the two-bag system uses two bags of fluids with identical electrolyte content but different dextrose concentrations, 0% and 10%.[@R20] The two bags are connected in a 'Y' fashion and by adjusting the infusion rates from each bag, the concentration of dextrose can be customized to prevent unpredictable excursions in blood glucose. The two-bag system has been more commonly used and exclusively studied in the pediatric population and has been found to be cost effective.[@R21] It has also been shown to result in more rapid improvement in bicarbonate and ketone correction and a trend toward faster improvement of hyperglycemia in DKA.[@R22] In one study, the two-bag system was well received by nursing and house staff because it was less labor intensive than the traditional one-bag system.[@R23]

To our knowledge, the two-bag system has not been compared with the one-bag system in the adult DKA population in the published literature. We performed a retrospective cohort study comparing the traditional one-bag protocol previously used at our institution with the newly initiated two-bag protocol. The primary purpose of our study is to compare the time to correction of the anion gap in adult patients with DKA.

Research design and methods {#s2}
===========================

Our study focused on adult patients with the diagnosis of DKA between the years of 2008 and 2015 who were admitted to the inpatient services of Riverside University Health System Medical Center. Our hospital is a safety-net hospital that serves the residents of Riverside County, California, with approximately 189 000 outpatient visits, 21 900 inpatient admissions, and 100 000 emergency room visits annually. Our hospital treated patients with DKA with a hospital-wide protocol that used the conventional one-bag system until 2013 when the treatment approach transitioned to the two-bag system ([supplementary appendix 1](#SP1){ref-type="supplementary-material"}). In our hospital, after initial diagnosis of DKA in the emergency room, the DKA protocol is initiated by ER physicians. In our institution, the DKA protocol is a hospital-wide protocol, which is followed in the inpatients units as well as in the emergency room. Any patient who requires an insulin drip automatically gets admitted to the ICU. If there is a delay in getting an ICU bed, the protocol is carried out in the ER. In our patient population, except a small group of patients with a diagnosis of mild DKA in the ER who improved on subcutaneous insulin therapy, all other patients were admitted for ICU care.
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All adult patients over the age of 18 years with an admitting diagnosis of DKA were retrospectively identified from the medical record searching through ICD-9-CM codes 250.10 (DKA in type 1 diabetes) and 250.11 (DKA in type 2 diabetes) diagnosis. Once a list of the patients was gathered, the diagnosis of DKA was verified. The following criteria were used to define DKA, a blood glucose ≥250 mg/dL and two of the following three criteria: serum bicarbonate (HCO~3~) \<18 mEq/L; serum beta-hydroxybutyrate (BHB) \>3 mmol/L; and pH \<7.30. Patients with a diagnosis of hyperosmolar hyperglycemic state as a final diagnosis in the chart were excluded. Ketosis from any other etiology, for example, alcoholic ketoacidosis, starvation ketosis, as a final diagnosis in the chart was excluded. Our chart review confirmed that there were no pregnant patients on our list eliminating any case of DKA associated with pregnancy. During initial chart review, we did not include any patient with DKA who was not started on an insulin drip eliminating cases of DKA treated with a subcutaneous insulin protocol. We identified 383 patients admitted with DKA that received treatment with either the one-bag system (n=249) or the two-bag system (n=143). Data were extracted from individual chart review using a standard data collection instrument that recorded the following information at the time of admission: patient's age and sex, hemoglobin A1c (HgbA1c), body weight, body mass index (BMI), pH, anion gap, admission blood glucose, comorbidities, HCO~3~, serum BHB, and the time of initiation and discontinuation of the DKA protocol. We also captured changes in anion gap, serum glucose, and bicarbonate level as patients received treatment for DKA.

Study outcomes {#s2a}
--------------

During the treatment of DKA, hyperglycemia is corrected faster than the ketoacidosis. Thus, we chose closure of the anion gap as our primary outcome measure which served as a surrogate for the resolution of DKA. Our secondary outcome was time to reach plasma glucose \<250 mg/dL, time to reach HCO~3~ level \>18 mmol/L, and hospital length of stay.

Sample size calculation {#s2b}
-----------------------

Because we could not find any prior study focusing on the timing of the closure of the anion gap addressing our research question, we took a small convenience sample of seven patients who were recently admitted with the diagnosis of DKA. The average time to close the anion gap was 10.4 hours with an SD of 6.4 hours. We decided that a 15% difference in time from this average would be considered clinically significant. Using an effect size of 0.25, an unpaired two-sided t-test, an alpha of 0.05, a beta of 0.2, and a power of 80%, the calculated sample size was 199 per group.

Data analysis {#s2c}
-------------

The descriptive analysis comparing the baseline characteristics of the two cohorts used the two-independent samples t-test for continuous variables and χ^2^ test for proportions for categorical variables. Outcome measures comparing the one-bag versus two-bag protocols used the two independent samples t-test to compare the time to closure of the anion gap (primary outcome measure) and time to reach plasma glucose \<250 mg/dL, time to reach HCO~3~ level \>18 mmol/L, and hospital length of stay (secondary outcome measures). The relationship between the time to closure of the anion gap and admission variables was assessed using the Pearson product--moment correlation. To further compare the times to closure of the anion gap between the two protocols while statistically controlling for the effects of admission variables that were not of primary interest, an analysis of covariance (ANCOVA) model was developed using time to closure of the anion gap as the dependent variable, and the following admission variables as covariates: patient's age, weight, BMI, admission pH and anion gap, BHB, blood urea nitrogen (BUN), serum creatinine, serum blood glucose, HgbA1c, and the Charlson Comorbidity Index.[@R24] A stepwise model selection method was used to determine the significant variables in the ANCOVA model. Data were entered into a Microsoft Excel spreadsheet and analyzed using SAS V.9.3.

This study was prospectively approved by the Institutional Review Board (IRB) of the Riverside University Health System Medical Center.

Results {#s3}
=======

A total of 383 patients admitted with DKA to our hospital were eligible for the study. In total, 249 patients admitted with DKA had received the conventional one-bag system and 134 patients were treated with the newly adopted two-bag system.

As shown in [Table 1](#T1){ref-type="table"}, the mean age of the patients was approximately 37 years and similar in the one-bag and two-bag cohorts. Patients of both groups had uncontrolled diabetes mellitus, with an average HgbA1c over 11 (11.7% vs 11.6%). Average BMIs were comparable in both groups (25.8 vs 24.4) as were body weights (75.5 vs 71.3 kg). Patients presented with a serum pH averaging 7.20 in both groups, and similar corrected anion gap levels (23.4 vs 23.8). Overall, the severities of patients' DKA at presentation were comparable with 25.70% versus 24.63% in mild DKA, 31.33% versus 38.81% in moderate DKA, and 42.97% versus 36.57% in severe DKA between one-bag and two-bag groups, respectively. Patients in both groups presented with significant hyperglycemia with blood glucose levels exceeding 400 mg/dL (473 vs 511 mg/dL). Interestingly, the BHB level was significantly higher in the two-bag group cohort (7.8 vs 4.4 mmol/L). BUN and serum creatinine levels were similar in both groups as was the Charlson Comorbidity Index.

###### 

Clinical characteristics of the study population

  ------------------------------------------------------------------------------------------------------------------
  Variable                          One-bag system\      Two-bag system\      p Value                       
                                    (total number=249)   (total number=134)                                 
  --------------------------------- -------------------- -------------------- ------------ ---------------- --------
  Age (years)                       249 (100%)           37.7 (±14.9)         134 (100%)   36.1 (±14.8)     0.23

  Male                              249 (100%)           144 (57.8%)          134 (100%)   73 (54.5%)       0.60

  Weight (kg)                       173 (69%)            75.5 (±22.7)         134 (100%)   71.3 (±20.5)     0.06

  BMI (kg/m^2^)                     152 (61%)            25.8 (±7.1)          125 (93%)    24.4 (±5.86)     0.11

  Initial pH                        177 (71%)            7.21 ± (0.14)        102 (76%)    7.24 (±0.16)     0.94

  BHB (mmol/L)                      156 (63%)            4.4 (±4.4)           127 (95%)    7.8 (±5.0)       \<0.01

  BUN (mg/dL)                       249 (100%)           23.1 (±14.4)         134 (100%)   23.8 (±14.3)     0.49

  Creatinine (mg/dL)                249 (100%)           1.48 (±1.68)         134 (100%)   1.40 (±0.90)     0.12

  Admission serum glucose (mg/dL)   233\* (94%)          473.6 (±198.0)       134 (100%)   511.7 (±193.3)   0.05

  Anion gap (mmol/L)                249 (100%)           23.4 (±6.3)          134 (100%)   23.8 (±5.9)      0.52

  HgbA1c (%)                        204 (82%)            11.7 (2.0)           105 (78%)    11.6 (2.0)       0.70

  Charlson comorbidity index        249 (100%)           1.66 (±1.18)         134 (100%)   1.54 (±1.11)     0.36
  ------------------------------------------------------------------------------------------------------------------

Baseline data are means ± SD. Some data are missing or not recorded in the chart to account for less than the total numbers in each group.

\*Sixteen missing values were recorded as 'high' by the glucometer (ie, \>600 mg/dL) and were recorded as unmeasurable in the chart.

BHB, beta-hydroxybutyrate; BMI, body mass index; BUN, blood urea nitrogen; HgbA1c, hemoglobin A1c.

Closure of anion gap was considered as a measure of correction of acidosis status and was considered as the surrogate of resolution of DKA in our analysis. The time to close anion gap was 13.56 hours in the conventional one-bag system protocol ([table 2](#T2){ref-type="table"}). This time period was decreased significantly to 10.94 hours in the patient group treated with two-bag protocol (p=0.0002). Time to reach plasma glucose below 250 mg/dL was significantly shorter with the two-bag protocol (p=0.0241). Time to raise serum HCO~3~ \>18 mmol/L was not statistically significant between the two groups, although it was shorter in the two-bag group (p=0.90). The incidence of hypoglycemic events, defined as a blood sugar \<70 mg/dL, was significantly less frequent with the two-bag protocol compared with the standard one-bag system (1.49% vs 8.43%, p=0.0064). The length of hospital stay was also modestly decreased by one half day in the two-bag group, although this difference did not reach statistical significance (p=0.099). The correlation coefficients between time to closure of the anion gap and admission variables are close to zero, indicating a very weak correlation between time to closure of the anion gap and the admission variables ([table 3](#T3){ref-type="table"}). In the ANCOVA model, the effects of all admission variables were not significant, except for the Charlson Comorbidity Index (t=−2.97, p=0.003). The protocol effect adjusted for the Charlson Comorbidity Index was significant in the ANCOVA model (t=3.10, p=0.0021), which further indicates the significant difference in the time to closure of the anion gap between the two protocols.

###### 

Primary and secondary outcomes

  ------------------------------------------------------------------------------------------------
                                                     One-bag system\   Two-bag system\   p Value
                                                     Mean (±SD)        Mean (±SD)        
  -------------------------------------------------- ----------------- ----------------- ---------
  Primary outcome                                                                        

   Time to close anion gap (hours)                   13.57 (±1.75)     10.95 (±1.63)     \<0.01

  Secondary outcomes                                                                     

   Time to reach plasma glucose\<250 mg/dL (hours)   9.15 (±1.38)      7.82 (±1.28)      0.02

   Time to reach serum HCO~3~\>18 mmol/L (hours)     19.95 (±1.99)     18.50 (±2.28)     0.36

   Hospital length of stay (days)                    4.86 (±3.63)      4.33 (±2.53)      0.09

                                                     **%**             **%**             

   Hypoglycemia (BS\<70 mg/dL)                       8.43              1.49              \<0.01
  ------------------------------------------------------------------------------------------------

Outcome measures comparing the one-bag versus two-bag protocols used the two independent samples t-test. For details, see online [supplementary appendix 2](#SP3){ref-type="supplementary-material"}.
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###### 

Correlation coefficients between time to closure of the anion gap and admission variables

  Variable      n     Correlation coefficient   p Value   Variable                          n     Correlation coefficient   p Value
  ------------- ----- ------------------------- --------- --------------------------------- ----- ------------------------- ---------
  Age (years)   383   −0.07887                  0.11      BUN (mg/dL)                       383   −0.00017                  0.99
  Weight (kg)   307   −0.06908                  0.21      Creatinine (mg/dL)                383   −0.07177                  0.10
  BMI           277   −0.08167                  0.16      Admission serum glucose (mg/dL)   367   0.04744                   0.35
  Initial pH    279   0.09654                   0.09      Anion gap (mmol/L)                383   −0.08352                  0.09
  BHB (mg/dL)   283   −0.02508                  0.66      HgbA1c (%)                        309   −0.03936                  0.48

The relationship between the time to closure of the anion gap and admission variables was assessed using the Pearson product--moment correlation. To further compare the times to closure of the anion gap between the two protocols while statistically controlling for the effects of admission variables, an analysis of covariance model was developed using time to closure of the anion gap as the dependent variable, and admission variables as covariates.

BHB, beta-hydroxybutyrate; BMI, body mass index; BUN, blood urea nitrogen; HgbA1c, hemoglobin A1c.

Conclusions {#s4}
===========

The purpose of this retrospective cohort study was to determine if a two-bag system significantly influenced resolution of DKA in adult patients presenting with DKA. Since anion gap is widely used by clinicians as a surrogate measure of resolution of acidosis in DKA, we evaluated the time to close anion gap as a primary end point for our study. Our results showed a reduction of 2.62 hours in the anion gap closure from 13.56 to 10.94 hours (p=0.0002) using the two-bag system. Plasma glucose levels improved to \<250 mg/dL earlier with two-bag protocol (9.14 vs 7.82 hours, p=0.0241), and there were significantly fewer episodes of hypoglycemia associated with the two-bag protocol (8.43% vs 1.49%, p=0.0069). However, neither the time to improve serum HCO~3~ level \>18 mg/dL nor the hospital length of stay differed in a statistically significant manner between the two groups. Both groups of the patients had similar comorbidities as measured by the Charlson Comorbidity Index indicating that the treatment protocol, rather than the disease-specific factors, played a greater role in the early closure of the anion gap. None of the other patient-specific factors played a significant role in the resolution of the anion gap ([table 3](#T3){ref-type="table"}).

The two-bag protocol has been used in pediatric patients with DKA and studies showed mixed results. In one study, the rate of serum HCO~3~ correction and the time to ketone correction were superior in the two-bag system[@R22]compared with the one-bag system; however, in the second study, there were no differences between the two groups.[@R23] Both studies were limited by small sample sizes (31 and 33 patients, respectively). Pediatric studies have demonstrated benefits of the two-bag system including decreased total number of intravenous bags used per patient, decreased cost of intravenous therapy,[@R21] and decreased response time for intravenous fluid changes[@R21].[@R23] In contrast to the few published studies on DKA management using the two-bag protocol, we compared anion gap closure. We have also used a significantly larger data set, potentially eliminating some of the limitations of the prior studies. However, we did not compare the volume of intravenous fluid used in each of the groups given the limitation of collecting accurate data in our retrospective study. A comparison of the published studies to date on the two-bag DKA protocol has been summarized in [table 4](#T4){ref-type="table"}.

###### 

Review of the published studies on the two-bag diabetic ketoacidosis protocol

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                           Study design                             Hospital setting                                             Patients                                    Outcome measure
  ----------------------------------- ---------------------------------------- ------------------------------------------------------------ ------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Grimberg *et al* [@R21]             Retrospective case--control              Single center inpatient---Philadelphia, Pennsylvania         20 pediatric patients (mean age 12--13):\   Two-bag system decreased number of intravenous bags used, response time by nursing to make changes in intravenous fluids, and costs of intravenous fluid therapy
                                                                                                                                            10 one-bag, 10 two-bag                      

  Poirier  *et al* [@R23]             Prospective non-blinded clinical trial   Single-center pediatric emergency room---Norfolk, Virginia   33 pediatric patients (mean age 11--14):\   Two-bag system decreased the time for nursing to make changes in intravenous fluids\
                                                                                                                                            16 one-bag,\                                No difference in blood glucose or bicarbonate correction nor the number of intravenous bags used
                                                                                                                                            17 two-bag                                  

  So and Grunewalder *et al* [@R22]   Retrospective series                     Single-center inpatient--- Greensboro, North Carolina        31 pediatric patients (mean age 13--14):\   Two-bag system corrected bicarbonate and ketone levels faster\
                                                                                                                                            9 one-bag, 22 two-bag                       No time difference for blood glucose and pH correction

  Current series 2010--2015           Retrospective cohort                     Single-center inpatient--- Riverside, California             383 adult patients (mean age 36--37):\      Two-bag system closed the anion gap faster (10.94 vs 13.56 hours)\
                                                                                                                                            249 one-bag\                                No significant time difference in hospital length of stay
                                                                                                                                            134 two-bag                                 
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To our knowledge, this is the first study comparing the two-bag protocol with the conventional one-bag protocol in an adult population. Strengths of this study include the large sample size and similar patient populations as evidenced by the baseline characteristics of the study groups. The two study groups did not differ in age, BMI, HgbA1c, BUN/creatinine, initial blood sugar, anion gap, initial serum pH or severity of DKA; however, the serum BHB levels were higher in the two-bag system group. The significantly elevated BHB concentration in the two-bag cohort may indicate patients in that group were more insulin deficient or had higher levels of metabolic stress. Despite that possibility, the two-bag protocol was associated with faster closure of the anion gap.

The key diagnostic feature in DKA is the elevation of total blood ketone concentrations in the background of relative or absolute insulin deficiency.[@R2] In patients with DKA, metabolic alterations due to insulin deficiency result in the accumulation of ketoacids causing an anion gap metabolic acidosis. In our study, BHB, the main metabolic product of ketosis,[@R25] was measured in the serum with a quantitative assay by the central laboratory as opposed to a semiquantitative nitroprusside reaction. Although the anion gap reflects the degree of acidosis in most situations, it is unreliable in cases of mixed acid--base disorders or in hyperchloremic metabolic acidosis presenting without a significant anion gap.[@R27] Similarly, there are limitations in the interpretation of the bicarbonate level as a measure of acidosis as well. For example, many patients with DKA present with nausea and vomiting, resulting in metabolic alkalosis. The bicarbonate level does not reflect the true level of acidosis in such situations or during severe volume contraction.[@R27] Therefore, the clinical decision-making involves evaluating multiple parameters of acid--base imbalance including serum anion gap, serum bicarbonate level, and measurement of serum pH. Our study did not compare resolution of acidosis by serial pH or beta-hydroxybutyrate measurements, which were not available in a large number of patients in our data set.

In our study, although the AG corrected earlier in DKA patients treated with the two-bag protocol, the time for serum bicarbonate level to reach \>18 was similar in both groups. Additionally, improvement of the bicarbonate level lagged behind the anion gap closure. This may indicate that relative hyperchloremia, resulting from the large volume of normal saline infusions during volume resuscitation, leads to the correction of the AG. However, ketone levels remained elevated for a longer duration accompanied by reduced serum bicarbonate levels until finally correcting with the insulin infusion. Both protocols were based on guidelines of fluid resuscitation in patients with DKA published by ADA[@R2]. Clinicians made the final decision regarding how much fluid was needed for a patient based on clinical findings, dehydration, and comorbidities. We could not collect the data on the total volume of intravenous fluid containing sodium chloride in our study population and do not know whether there was any difference in the intravenous fluid administered.

In this study, we only included patients with DKA admitted to the ICU setting. The pattern of ICU utilization for patients with DKA varies among institutions. More than 50% of patients with DKA are admitted to the ICU.[@R5] The financial burden of DKA management is significant, with estimated mean expenses for a single hospitalization ranging from \$7470 to \$20 864.[@R28] The itemized expense calculation of DKA costs shows that a significant cost in DKA management involves the cost of the ICU stay and laboratory testing.[@R28] Although we found that the anion gap closure was earlier with two-bag protocol, whether this will result in any reduction of cost was not addressed in this study. A randomized prospective study needs to be designed to answer these questions. In our population, the average length of stay was \>4 days in both groups. Although we could not compare duration of ICU stay, in patients treated with the two-bag protocol, the average length of hospital stay decreased by half a day, although the difference did not reach statistical significance. In a recent report published by the CDC,[@R4] the average length of hospital stay was found to be decreased to 3.4 days for hospital discharges with DKA as the first-listed discharge diagnosis. The average length of hospital stay in our study was above the national average regardless of the protocol used. Multiple factors have contributed to the shortened length of hospital stay in the published literature including widespread use of protocols for DKA management, enhanced staff training, and involvement of specialized diabetes nurses.[@R29] There are additional disease-specific factors that could influence the length of hospital stay including gastroparesis, concurrent infection, cognitive impairment, and rehabilitation requirements.[@R29] Our study did not compare the disease-specific factors that potentially could have influenced the length of hospital stay. Although, as a safety net medical center, we serve a patient population with a low socioeconomic status and higher burden of comorbidities, which may contribute the longer length of stay in our study. Another study, in an inner-city population with predominantly African American patients, showed the average length of stay of 4.5 days, which is similar to our study.[@R30]

This study had several limitations including a retrospective study design and a patient population limited to a single safety net medical center, which may limit its external applicability. The large Hispanic population that our hospital serves has a very high prevalence of obesity and uncontrolled diabetes. In addition, we could not reach our calculated sample size for 199 for the two-bag group (fell short by 56 patients), raising possibility of a type II error. Because of the retrospective nature of our study, we also cannot exclude the possibility that temporal changes in the management of DKA other than the introduction of the two-bag protocol could have occurred during the time span of the study that were not collected by our standardized data collection instrument. To minimize this bias, management of DKA from 2008 to 2015 was driven by standardized hospital-wide protocols and the Charlson Comorbidity Indices in the two groups were comparable. In spite of this, some key laboratory information such as pH, BHB, and admission HbA1c was not systematically collected in all patients. For these three variables, no differences were found on admission between the two groups and in our ANCOVA model. While we found an approximate half-day reduction in the length of stay using the two-bag protocol, this difference was not statistically significant and our study may have been underpowered to detect this secondary outcome. Finally, inherent in any retrospective study, residual confounding from other unmeasured or inaccurately measured variables excludes any definitive statements of causality and we can only state that the two-bag protocol was associated with a faster time to closure of the anion gap and significantly fewer episodes of hypoglycemia.

Our study supports the use of the two-bag protocol as another method of DKA treatment. The fundamentals of DKA treatment, for example, volume repletion and correction of electrolyte imbalance, are similar in both groups. Two-bag protocol may be beneficial in certain clinical settings due to faster resolution of anion gap, faster rate of improvement of blood sugar, and lesser episodes of hypoglycemia. Future studies will indicate whether faster anion gap closure results in overall cost reduction of DKA management. Reduction of hypoglycemic events associated with the two-bag protocol has a direct impact on patient safety. The two-bag system can be easily adapted as an ICU protocol with minimal staff training. This study supports the use of the two-bag system in treating adult patients with DKA. A larger, randomized prospective study to further study this issue would be beneficial.
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